Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Last revision Both sides next revision
neuropathy [2015/09/20 17:44]
sflitman [Response Form]
neuropathy [2016/01/31 13:53]
sflitman [Neuropathy]
Line 1: Line 1:
 ===== Neuropathy ===== ===== Neuropathy =====
- 
-We have no currently enrolling trials, but will update this page when a new trial becomes available. 
  
 <​html><​!-- <​html><​!--
-^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^ +We have no currently enrolling trials for this indication, but will update this page when a new trial becomes available.
-| Mild Cognitive Impairment and Mild AD | Intravenous anti-amyloid antibody ​ |  II  |  Yes  |  16%  |  52 weeks  |  1+ years  | +
-| Moderate and Severe AD with Agitation ​ | Novel oral agent |  II  |  Yes  |  50%  |  12 weeks  |  24 weeks  | +
-| Mild AD | Intravenous ​ mAb antibody ​ |  III  |  Yes  |  50%  |  18 weeks  |   ​Yes ​  | +
-| Mild to Moderate AD | Oral nicotinic alpha-7 ligand |  III  |  Yes  |  33%  |  26 weeks  |  26 weeks  |+
 --></​html>​ --></​html>​
 +
 +^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^
 +| Diabetic Peripheral Neuropathy Pain | Novel oral agent  |  III  |  Yes  |  25%  |  12 weeks  |  52 weeks  |
 +
 ====== Response Form ====== ====== Response Form ======
  
Print/export
QR Code
QR Code neuropathy (generated for current page)